Doctors, researchers and drugmakers are designing new strategies to help people with intellectual disabilities such as Down syndrome and Fragile X syndrome make informed decisions about participating in clinical trials. New informed consent practices include simpler words, pictures, flip charts, videos and audiovisual tools to explain potential risks and benefits of clinical trial participation.

Related Summaries